Protocols for antibiotic use in primary and secondary prevention of rheumatic fever

South African Medical Journal

Volumn 96, Issue 3 II, 2006, Pages 240-

  Mayosi, Bongani M ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

BENZATHINE PENICILLIN; ERYTHROMYCIN; PENICILLIN V;

AFRICA; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL FEATURE; DRUG EFFICACY; ENDEMIC DISEASE; GOOD CLINICAL PRACTICE; HUMAN; PATIENT COMPLIANCE; PENICILLIN ALLERGY; PRACTICE GUIDELINE; PRIMARY PREVENTION; PUBLIC HEALTH; RHEUMATIC FEVER; SECONDARY PREVENTION; SORE THROAT; STREPTOCOCCUS INFECTION; TONSILLITIS; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; ERYTHROMYCIN; HUMANS; PENICILLIN G, BENZATHINE; PENICILLIN V; PRACTICE GUIDELINES; RHEUMATIC FEVER;

EID: 33645297361     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Department of Health, South Africa. National guidelines on primary prevention and prophylaxis of rheumatic fever and rheumatic heart disease for health professionals at primary level. S Afr Med J 1999; Suppl 2 (Cardiovasc J S Afr): C91-C94.
2. World Health Organization. Rheumatic fever and rheumatic heart disease. Report of a WHO expert consultation, Geneva, 29 October - 1 November 2001. http://www.who.int/cardiovascular_diseases/resources/trs923/en/ (last accessed 15 November 2005).
3. Manyemba J, Mayosi BM. Intramuscular penicillin is more effective than oral penicillin in secondary prevention of rheumatic fever - a systematic review. S Afr Med J 2003; 93: 212-218.
4. Robertson KA, Volmink JA, Mayosi BM. Antibiotics for the primary prevention of acute rheumatic fever: a meta-analysis. BMC Cardiovasc Disord 2005; 5: 11.
5. Robertson KA, Volmink JA, Mayosi BM. Lack of adherence to the national guidelines on the prevention of rheumatic fever. S Afr Med J 2005; 95: 52-56.